TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-32698-3.pdf
Reference31 articles.
1. Liubota, R. V., Zotov, A. S., Vereshchako, R. I., Liubota, I. I. & Zaychuk, V. V. Risk Factors of the Invasive Breast Cancer Locoregional Recurrence. BioMed research international 2015, 789646, https://doi.org/10.1155/2015/789646 (2015).
2. Mendes, T. F., Kluskens, L. D. & Rodrigues, L. R. Triple NegativeBreast Cancer: Nanosolutions for a Big Challenge. Advanced science 2, 1500053, https://doi.org/10.1002/advs.201500053 (2015).
3. Tektonidis, M. et al. Identification of intrinsic in vitro cellular mechanisms for glioma invasion. Journal of theoretical biology 287, 131–147, https://doi.org/10.1016/j.jtbi.2011.07.012 (2011).
4. Stamenkovic, I. Extracellular matrix remodelling: the role of matrix metalloproteinases. The Journal of pathology 200, 448–464, https://doi.org/10.1002/path.1400 (2003).
5. Noel, A., Jost, M. & Maquoi, E. Matrix metalloproteinases at cancer tumor-host interface. Seminars in cell & developmental biology 19, 52–60, https://doi.org/10.1016/j.semcdb.2007.05.011 (2008).
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reversal Gene Expression Assessment for Drug Repurposing, a Case Study of Glioblastoma;2024-09-09
2. Non-Muscle Myosin II A: Friend or Foe in Cancer?;International Journal of Molecular Sciences;2024-08-30
3. Tissue factor pathway inhibitor-2 (TFPI-2)—an underappreciated partaker in cancer and metastasis;Cancer and Metastasis Reviews;2024-08-17
4. Dual Role of Tissue Factor Pathway Inhibitor 2—A Novel Serodiagnostic Marker for Ovarian Cancer—In Human Cancers;International Journal of Translational Medicine;2024-06-28
5. Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target;BMC Cancer;2024-06-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3